Understanding why certain brain cells are more vulnerable in Parkinson's disease
Developmental underpinnings of substantia nigra vulnerability
This study is looking at certain brain cells that are especially at risk in Parkinson's disease to understand why they break down, which could help find new ways to treat the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11031947 on NIH RePORTER |
What this research studies
This research investigates the specific brain cells in the substantia nigra that are particularly vulnerable to degeneration in Parkinson's disease. By examining the developmental differences and intrinsic properties of these cells, the study aims to uncover the mechanisms behind their vulnerability. The researchers utilize advanced genetic strategies and single-cell profiling to identify distinct subtypes of dopamine neurons and their responses to toxins. This work could lead to a better understanding of Parkinson's disease and potential new therapeutic targets.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease, particularly those experiencing motor symptoms.
Not a fit: Patients with other neurological disorders unrelated to dopamine neuron degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for Parkinson's disease by targeting the vulnerable brain cells responsible for motor symptoms.
How similar studies have performed: Previous research has shown promising results in understanding neuron vulnerability in Parkinson's disease, indicating that this approach could yield valuable insights.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Awatramani, Rajeshwar B — Northwestern University at Chicago
- Study coordinator: Awatramani, Rajeshwar B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.